We partnered with radiologists, technologists and patients to create a mammography platform that is designed to meet each of their needs – easing patients’ anxieties, making technologists’ jobs easier and helping radiologists diagnose with greater confidence.

The result of our rigorous, collaborative design process is the Senographe Pristina: comfort for patients, confidence for technologists and clarity for radiologists.

Pristina is compatible with Pristina Dueta the industry’s first patient-assisted compression device, that gives patients a sense of control during their mammograms.

SenoBright™ HD Contrast-Enhanced Spectral Mammography technology offers an astonishingly clear way of seeing what matters in the breast. It improves breast cancer detection up to 20% in dense breast.

With Serena Bright™, no longer do you need to leave the mammography suite to biopsy lesions identified with contrast. The ability to biopsy with contrast allows you to confidently locate the target and biopsy with certainty. Lesions identified with contrast may be difficult to biopsy under conventional techniques. Contrast mammography allows you to be more certain whether biopsy is necessary and now with Serena Bright, contrast-enhanced guided biopsy provides exceptional clinical confidence and accuracy without shifting to MRI.

The LOGIQ E10 Series is your trusted ultrasound companion supporting you and your patients in each stage of the clinical care pathway from diagnosis to treatment planning and follow up of breast disease. The cSound™ Imageformer technology, in combination with a matrix probe, delivers exquisite images with high spatial and contrast resolution, to help you see more at an earlier stage. Comprehensive tools can also help increase your confidence in classification and staging of the found lesions (e.g. 2D SWE can help in a non-invasive classification of the breast lesions.)

The dedicated Breast Assistant package, enhancing the workflow in your breast examinations, is now completed with the new KOIOS DS™* technique, AI-based diagnostic support tool, that helps confidence in the diagnosis and staging of breast lesions, decreasing BI-RADS classification variability and number of biopsies to false positive lesions.

*Products may not be available in all countries and regions.

As opposed to the VISIBLE that matters to you, meaning early detecting and rapid diagnosis by SEEING the tumours, we’re introducing THE INVISIBLE THAT MATTERS, for woman.
We want to support you in the remaining piece of this life-saving equation, meaning woman self-efficacy, and have make them becoming actors in her breast care journey.

Come and “Meet Cecilia O”, our Patient Advocate, part of our Advisory Board, where the voice of patient matters as a fundamental pillar.
She’s also present within our community, for inspiration and storytelling, in a peer to peer approach.

We designed our digital mobile X-ray system, AMX 240, with these complex care areas in mind. Its high-resolution 100-micron digital detectors, FlashPad™ HD, enable you to see fine details with exceptional contrast. AMX 240 includes two different detector sizes.

They are thin, light and can be used with your surgical table to quickly get the image you need. In most cases, you can slide the 35cm x43cm detector directly in the surgical table or position with accessory positioners. Its unique, adaptive, wireless technology enables automatic channel switching to improve image transfer and avoid wireless interference with other surgical equipment on the hospital network.

Addresses the challenges of 3D mammography reading with a high-performing cancer detection and workflow solution.

• Analyzes each individual slice, detecting both malignant soft tissue densities and calcifications with unrivaled accuracy, including subtle and very small lesions, even in dense breasts.

• Improves radiologist’s average cancer detection performance by 8% while offering critical timesaving benefits by reducing reading time by 52.7%*.

* Conant, E. et al. (2019). Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis. Radiology: Artificial Intelligence. 1 (4). https://pubs.rsna.org/doi/10.1148/ryai.2019180096

Rapid Progress. Provide patient access to a rapid screening, diagnosis, and treatment plan pathway, reducing patient anxiety and improving overall satisfaction.

Fewer False Positives. Minimize repeat tests and scans due to false positives.

Better Care. Improve treatment appropriateness and—ultimately—outcomes. Enable effective screening for all patients including those with dense breasts.

Bend the Cost Curve. Reduce the number of procedures necessary to reach early stage diagnosis.

Fast and simple set up. Pristina Serena transforms a screening room into an interventional suite in just two minutes* with the dedicated add-on biopsy kit without requiring a long and mechanical needle installation.

Pristina Serena is swift and streamlined. Its intuitive touchscreen user interface outlines the procedure step by step. Breast biopsy procedure can be performed in less than 15 minutes*.

* Data on file with GE Healthcare, 2018.

Invenia ABUS 2.0 transforms breast care from reactive to proactive. The sole FDA-approved ultrasound screening technology is specifically designed for detecting cancer in dense breast tissue. Clinical studies have demonstrated a 57% relative increase in invasive cancer detection* for dense breasts.

Innovation is key: cSound Imageformer technology is providing extraordinary image quality and the Reverse Curve™ transducer enhanced comfort for patients and users.

Reproducibility, operator independency and the 3D coronal plane access are leading into clinical and operational advancements along the Breast Care Pathway from screening to staging and monitoring. Our support goes beyond technology with the digital Mastery Education Portal for Physicians, Implementation guidance and Marketing Kit.

* Wilczek B, European Journal of Radiology (DOI: 10.1016/j.ejrad.2016.06.004

DXAVision™ provides BMD and Body Composition in one easy, unified workflow. The DXAVision™ scan is designed to improve operator efficiency, resulting in a DXA scan that is up to 40% faster* and a better experience for your patients.

* Data on file with GE Healthcare, April 2019.

Definium 656 HD is GE’s all new digital radiographic system powered by Helix™ 2.0 advanced image processing and featuring an expanded suite of workflow automation & analytics tools.
With Definium 656 HD, no more unnecessary X-ray image adjustments and repeated exams. Just sharp detail and the balanced contrast and brightness you need at low dose, right from that very first image.

Helix advanced image processing algorithms harness the full high-resolution power and exceptional dose efficiency of FlashPad HD detectors to deliver outstanding clarity and extraordinary anatomical detail where it matters most.

Critical Care Suite 2.0 is a collection of AI algorithms embedded on X-ray systems for automated measurements, detection and triage of critical cases, and quality control. In these challenging times, every minute counts when dealing with high-risk procedures such as tracheal intubation* and critical conditions including pneumothorax.

Thoracic Care Suite with Lunit INSIGHT CXR offers AI detection of eight abnormal chest radiograph findings which also support Tuberculosis detection and help find Pneumonia or ground glass opacities, which are indicative of COVID-19. A suite of Artificial Intelligence algorithms that analyze Chest X-rays and flag abnormal findings.

* Stephen E. Lapinsky. Endotracheal intubation in the ICU. Crit Care. 2015; 19(1): 258.

Advancing the World of Health.

The EnCor Enspire™ Breast Biopsy System provides control operations for specialized biopsy instruments intended to acquire tissue samples of suspected breast abnormalities. The EnCor Enspire™ Biopsy System is designed to recognize individual biopsy drivers and provide a user interface and to accept inputs when used for specific procedures. Each biopsy driver type performs unique functions.

Advancing the World of Health.

The BD EleVation™ Breast Biopsy System is a handheld, self-contained, single insertion, multiple sample biopsy device and is intended to be used with ultrasound guidance. The device can obtain and store multiple samples with a single insertion of the BD EleVation™ Probe. The components of the BD EleVation™ Breast Biopsy System are designed to operate safely when used together for diagnostic sampling during a breast biopsy procedure. The device consists of a battery-powered, reusable BD EleVation™ Driver and a disposable BD EleVation™ Probe with a usable needle length of 10cm and a sample container.